मुख्य मजकुरावर जा
शनि, २१, नोव्हें २०२६ · पुणे
Pharma Solutions Indiaबातम्या · नोकऱ्या · MSPC मदत · क्लासेस
बातम्यांकडे परत
pharma १६ ऑग 2 मिनिटांचं वाचन· New Delhi, India

PM Modi Urges New Drug Innovation: India’s Pharma Sector at a Turning Point

Big boost for India’s pharma sector!

लेखक Pharma Solutions India · १६ ऑगस्ट, २०२५

PM Modi Urges New Drug Innovation: India’s Pharma Sector at a Turning Point

एका नजरेत

ठिकाणNew Delhi, India
विभागpharma
प्रकाशित१६ ऑगस्ट, २०२५
India is the pharmacy of the world, but we must push harder for new drug innovations – PM Modi

मुख्य मुद्दे

  • PM Modi urges accelerated focus on new drug development in India
  • India recognized globally for affordable generics and vaccine supply leadership
  • Call to action for pharma sector to innovate beyond current strengths

In a recent address in New Delhi, Prime Minister Narendra Modi highlighted India’s unparalleled role as the *pharmacy of the world*, thanks to its leadership in supplying low cost generic medicines and vaccines globally. However, he stressed that the country must now channel more energy into developing new drugs to stay ahead in the competitive pharmaceutical landscape. Modi’s remarks come at a time when India’s pharma industry is already a powerhouse, contributing over 60% of global vaccine production and supplying 20% of the world’s generic drugs. But with rising competition from countries like China and increased regulatory scrutiny, the PM’s push for innovation signals a strategic shift. Industry experts suggest this could lead to: - More R&D investments from both public and private sectors - Stronger collaborations between academia and pharma companies - Policy reforms to fast track drug approvals and clinical trials The government may also introduce incentives for startups and biotech firms working on breakthrough therapies, especially in areas like oncology, rare diseases, and antimicrobial resistance. *This is a defining moment for India’s pharma story,* said a senior health ministry official. *We’ve mastered generics; now it’s time to lead in innovation.*

India’s strength in generics is unmatched, but the next frontier is original research. The PM’s emphasis on new drug development could redefine our position from a supplier to an innovator.
Dr. Ranjit Shahani, Former President, Indian Pharmaceutical Alliance

For more on India’s pharma policies, check: - NITI Aayog’s Pharma Vision 2030 ( ) - Department of Pharmaceuticals updates ( ) - WHO’s Global Vaccine Market Report ( ) *Have thoughts on India’s pharma future?* Drop a comment below!

niti.gov.inpharma.gov.inwho.int

हा सारांश फार्मा सोल्युशन्स इंडियाच्या टीमने तयार केला आहे. काही करण्यापूर्वी तारीख, फी आणि पात्रता संबंधित कार्यालयाकडे तपासून घ्या. संपादकीय धोरण · अस्वीकरण.

Advertisement